Citic Niya (600084.SH) released its semi-annual report for 2024, with operating revenue of 66.9252 million yuan, a year-on-year decrease of 45.29%; net income attributable to shareholders of the listed company was -4.9954 million yuan.

- Headlines
- CITIC Niya (600084.SH): net loss of 4.9954 million yuan in the first half of the year.
中信尼雅(600084.SH):上半年净亏损499.54万元
CITIC Niya (600084.SH): net loss of 4.9954 million yuan in the first half of the year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Log In for the Full List
Latest
08:07
A USA judge has allowed the Department of Efficiency to access the Department of Education database.
CHINA BEST0.00%
08:07
CSPC PHARMA (01093): CSPC PHARMA and RADIANCE BIOPHARMA have entered into an exclusive licensing agreement for SYS6005.
CSPC PHARMA+1.68%
08:06
Sinolink: In the short term, the 'volatile market' in Hong Kong stocks will continue.
Sinolink-2.37%
Investment Course

Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.